Skip to main content

Table 5 Cytotoxicity of L-OHP on OCUM-2MD3/L-OHP (μg/mL%, x ¯ ± S, 72 h).

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Group 600 300 150 75 37.5 IC50
OCUM-2MD3 50.2 ± 1.8 40.6 ± 1.5 25.4 ± 2.7 19.2 ± 1.4 8.3 ± 1.7 522.3
OCUM-2MD3/L-OHP 38.4 ± 1.1* 24.7 ± 2.3* 17.5 ± 2.5* 9.8 ± 1.5* 5.6 ± 3.2* 1057.0
  1. *Compared with OCUM-2MD3 Group P < 0.05